RMD Resmed Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
20:15
May 04
May 04
The tweet simply tags ResMed as a follow-up ticker without providing any directional opinion or market analysis.
HIGH
00:57
May 01
May 01
Bearish view on RMD as CFO departure on top of decelerating US device sales, even on the easiest year-over-year comparison, signals underlying operational weakness.
HIGH
00:40
May 01
May 01
The CFO's retirement amid slowing US device sales signals potential internal turmoil and weakening demand for ResMed's core products.
HIGH
00:19
May 01
May 01
Bearish view on medtech stocks/ETF as the speaker expects further multiples compression tomorrow, driven by a directional bearish view on the sector's valuation.
HIGH
14:49
Apr 27
Apr 27
Short RMD due to GLP-1-driven CPAP attrition, slowing growth into FY27, and no multi-product floor for a single-product medtech.
HIGH
11:43
Apr 22
Apr 22
Bearish view on DXCM, RMD, and ISRG because accelerating declines in bariatric procedures for ISRG signal that GLP-1 drugs are reducing demand for related medical devices and services, extending to diabetes management and respiratory care.
HIGH
11:42
Apr 22
Apr 22
Bearish view on DXCM and RMD because accelerating declines in bariatric procedures due to GLP-1 drug adoption signal a structural headwind for companies exposed to obesity and diabetes-related treatment demand.
HIGH
About RMD Analyst Coverage
Buzzberg tracks RMD (Resmed) across 1 sources. 0 bullish vs 1 bearish calls from 1 analysts. Sentiment: mixed to bearish. 7 total trade ideas tracked.